Webpackaging logo

Tekni-Plex acquires Johnson Plastic Group, expanding medical device footprint

  • Tekni-Plex
North America, Health, Medical, Diagnostics

Tekni-Plex Healthcare has acquired precision extrusion manufacturer Johnson Plastic Group (JPG) as part of a strategy to expand the company’s patient care solutions platform.

Located in Mexicali, Mexico, Johnson Plastic Group specializes in precision extrusions for medical device applications. The company provides complete extrusion solutions into a variety of medical device applications for interventional and therapeutic procedures.

The acquisition expands Tekni-Plex Healthcare’s medical device capabilities and broadens the division’s global footprint by adding a presence in Mexico.

“This acquisition makes total sense for us and improves our ability to service our customers,” said Chris Qualters, CEO of Tekni-Plex Healthcare. “It builds upon our existing solutions capabilities and increases our geographic reach, bringing us close to our key customer base in Mexico and the Baja region. It also allows us to leverage JPG’s expertise across our entire global customer base and healthcare end markets.”

Qualters noted: “The addition of JPG continues to build upon our innovative patient care solutions platform centered on material science and process technologies. We are looking forward to creating an even more robust set of offerings and solutions that help improve patient outcomes.”

Enrique Preciado, JPG owner and general manager, said: “We are truly excited to become part of Tekni-Plex Healthcare. We now will be able to provide even greater opportunities for our employees and a broader range of products and material science solutions for our customers.”

See also

Colorite announces North American launch of Cellene thermoplastic elastomer compounds for medical devices

Colorite, a Tekni-Plex company, is introducing its Cellene line of thermoplastic elastomer compounds to the North American marketplace for medical device applications. Cellene thermoplastic elastomer compounds are suitable for a wide variety of medical devices, as well as packaging and other regulated markets. Cellene compounds are formulated to be silicone, latex, phthalate, halogen and PVC-free using FDA-compliant raw materials to meet USP Class VI and ISO 10993 standards.

  • Company News
  • English
  • Modified 08 Oct 2021
  • Hits 219